Adaptas Solutions
Palmer, MAComprehensive sample-to-answer solutions for laboratory science, analytical, and clinical equipment
Acquired by IMI plc in 2021
View CompanyWith more than 30 years dedicated to the life sciences sector, Ampersand Capital Partners has established a track record as the industry leader at the forefront of transformative investments serving science.
Our current and legacy portfolio is a testament to this vision, which includes a range of diverse companies providing scientific innovations, technologies, and services.
Ampersand transcends a traditional investment role, employing our unique expertise to closely collaborate with portfolio company founders and leadership teams on both a scientific and growth strategy level. This fully integrated approach has been the foundation of many success stories, forging both founders and companies into industry leaders.
Comprehensive sample-to-answer solutions for laboratory science, analytical, and clinical equipment
Acquired by IMI plc in 2021
View Company
Genomic and bioinformatic services for researchers working on projects ranging from exploratory to clinical.
View Company
CRO providing integrated small and large molecule discovery and bioanalytical, drug metabolism and pharmacokinetic, and pharmacology services
Acquired by Charles River Laboratories in 2016
View Company
Multi-phase pharmaceutical development and manufacturing for small and large molecules
View Company
Procurement and logistics management of high-quality human tissue and cells for drug discovery and academic research
View Company
Development, manufacture, and marketing of branded and generic prescription pharmaceuticals
View Company
CDMO focused on the development and commercialization of therapies targeting the human microbiome
Acquired by Recipharm in 2022
View Company
Commercial biologics CDMO focused on the development and CGMP manufacture of biopharmaceuticals.
View Company
Contract development, manufacturing, and testing solutions for generic pharmaceutical products
Acquired by Cambrex in 2018
View Company
Premier provider of diagnostic and therapeutic services focused on skin, soft tissue, and bone of the lower extremities
Acquired by Consonance Capital in 2016
View Company
Integrated clinical research technology solutions for the pharmaceutical, biotechnology, medical device, and contract research industries
Acquired by Cinven in 2016
View Company
Full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera
View Company
Life sciences reagents and critical raw materials, custom synthesis, and manufacturing services
View Company
Global leader of innovations for clinically efficacious active healing and surgical orthobiologics
IPO in June 2024 (Nasdaq: BVS)
View Company
Provider of clinical and commercial supply of viral vectors for in vivo gene and ex vivo cell therapies
Acquired by Thermo Fisher Scientific in 2019
View Company
Cutting-edge spatial biology and multi-omic tools for biomedical research
Acquired by Bruker Nano in 2020
View Company
Biomaterials, custom research services, and clinical laboratory services
Acquired by Charles River Laboratories in 2020
View Company
Provider of ion channel testing services for drug safety and discovery
Acquired by Charles River Laboratories in 2014
View Company
Design and development of large-scale manufacturing for interventional catheter-based devices and implants
View Company
Full-scale contract manufacturing solutions for high-quality class III medical devices
Acquired by Confluent Medical Technologies in 2018
View Company
Early-stage patient population studies with a focus on Human Abuse Liability, addiction, pain, psychiatry, neurology, pediatric, and infectious disease services
Acquired by PRA in 2013
View Company
Global manufacturer of high-performance plastic packaging for the pharmaceutical, specialty chemicals, and logistics industries.
View Company
Development and commercialization of value-added medical kits for compounding pharma
Acquired by NovaQuest in 2016
View Company
Manufacturer of fully automated ELISA processing systems for laboratories and research clinics
Acquired by Telegraph Hill in 2017
View Company
Manufacturing solutions for complex formulas in the form of tablets, chewable tablets, and capsules
Acquired by DCC Health and Beauty Solutions in 2018
View Company
Contract manufacturer of textile biomaterials and specialty plastic components for medical products
Acquired by Confluent Medical Technologies in 2016
View Company
Leader in spatial biology and biomarker analysis for clinical research and drug development
View Company
CDMO specializing in the development, scaling, and manufacturing of polyethylene glycol (PEG) reagents
View Company
Developer of innovative diagnostic tests, software, services, and educational products for molecular diagnostic testing
Acquired by Eurobio Scientific in 2022
View Company
Global leader in R&D genomics services
Acquired by Brooks Automation in 2018
View Company
Contract development and manufacturing for a range of viral vectors to support the development of cell and gene therapies
View Company
Specialized laboratory services for hematology and oncology
Acquired by NeoGenomics in 2018
View Company
Global leader in peptide synthesis and bioanalytical technology for research, drug discovery, preclinical and clinical development, and bioprocessing
Acquired by Mesa Laboratories in 2019
View Company
Manufacturer of agglomerated and microencapsulated food and nutrition ingredients
Acquired by Balchem Corporation in 2017
View Company
Provider of complex molecular analysis for the early diagnosis and the treatment of cancer
View Company
A full-service ophthalmology-focused contract research organization (CRO)
View Company
CRO network supporting a variety of therapeutic applications, including CNS diseases, cardio-metabolic and renal diseases, and infectious diseases and vaccines
View Company
Collection and fractionation of blood plasma for the production of plasma-derived therapies
View Company
Provider of antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, and bioanalytics
Acquired by Curia in 2021
View Company
Manufacturer of in vivo antibodies for flow cytometry, immunohistochemistry, and spatial biology studies
View Company
Lexington Medical designs and manufactures high-performance endoscopic stapling devices, which are proudly made in the USA and used in a wide range of surgical procedures.
View Company
Solutions for the identification and protection of those at risk of lead exposure
Acquired by Meridian Biosciences in 2016
View Company
Scientific instrument developer specializing in compact, portable, and benchtop nuclear magnetic resonance and magnetic resonance imaging products
View Company
Preclinical CRO advancing R&D for bioanalytical, pharmacokinetic, and pharmacology studies
View Company
Global CDMO providing topical and transdermal product design, development, and manufacturing services
View Company
Leading designer and manufacturer of medical technology solutions for minimally invasive surgical devices
Acquired by Helix Medical in 2012
View Company
Specialty CRO providing cryo-EM solutions for the discovery and development of novel therapeutics
View Company
Leading developer of automated cell counting and image cytometry solutions
Acquired by PerkinElmer in 2021
View Company
R&D solutions for the development of immunotherapeutics, including biologics, antiviral drugs, and cell and gene therapies
Acquired by Q2 Solutions in 2022
View Company
High-quality instruments and assays for life sciences research
View Company
Global provider of clinical and epidemiology research solutions with a focus on vaccines and infectious diseases
View Company
Medical device coating application services, including complex masking and coating, value-added surface treatments, and marking technologies
Acquired by Integer in 2025
View Company
Leading global provider of biopharmaceutical, cell, and gene therapy analytical solutions
View Company
Drug product services for all common dosage forms from pre-formulation and clinical development through to scale-up and commercial manufacturing
View Company
Analytical services for the testing of raw materials, formulated products, packaging, and medical devices
View Company
Leading compounding pharmacy focused on the companion animal market
Acquired by Vets First Choice in 2017
View Company
Pioneering laboratory credited with providing the first microarray-based cytogenetic diagnostics for intellectual disability and birth defects
Acquired by PerkinElmer in 2010
View Company
Designs and manufactures Fourier Transform Infrared (FTIR) accessories, Sample Preparation/XRF, Process Cells, IR polarisers products for atomic and molecular spectroscopy
View Company
Leading international provider of preclinical and clinical histology, pathology, image analysis, and specimen archiving services
View Company
High-throughput solutions for automated workflows in pharmaceutical and CDMO applications
View Company
Medical device developer providing comprehensive design and manufacturing services
View Company
mRNA CDMO dedicated to enhancing industry access to mRNA, LNP-mRNA, and associated services
View Company
Developer and manufacturer of suspension and adherent cell-based and egg-based viruses
Acquired by Recipharm in 2022
View Company
Diagnostic laboratory specializing in infectious diseases, immunology, and allergy testing for immunocompromised and critical patients
Acquired by Eurofins Scientific in 2014
View Company
Lentiviral vector GMP CDMO providing process development, manufacturing and analytical testing
View Company
Custom peptide synthesis and antibody production
Acquired by Biosynth Carbosynth in 2022
View CompanyAmpersand Capital Partners stands at the forefront of life sciences investments, where scientific innovation meets strategic investment acumen. Ampersand’s value extends beyond traditional investment models to active collaboration with founders of portfolio companies with the goal of propelling these enterprises to the forefront of their respective industries.
Explore Founder & CEO Stories